Evidence map›Paper›PMID 37314333›Full record

ArticleMicrobiology spectrum2023

Daily SARS-CoV-2 Nasal Antigen Tests Miss Infected and Presumably Infectious People Due to Viral Load Differences among Specimen Types.

Alexander Viloria Winnett, Reid Akana, Natasha Shelby, Hannah Davich, Saharai Caldera, Taikun Yamada, John Raymond B Reyna, Anna E Romano, Alyssa M Carter, Mi Kyung Kim and 6 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Validating Combination Throat-Nasal Swab Specimens for COVID-19 Tests Would Improve Early Detection, Especially for the Most Vulnerable.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Alexander Viloria Winnett *California Institute of Technology, Pasadena, California, USA.
Reid Akana *California Institute of Technology, Pasadena, California, USA.
Natasha Shelby *California Institute of Technology, Pasadena, California, USA.ORCID 0000-0001-9097-3663
Hannah DavichCalifornia Institute of Technology, Pasadena, California, USA.ORCID 0000-0001-6880-3086
Saharai CalderaCalifornia Institute of Technology, Pasadena, California, USA.
Taikun YamadaPangea Laboratory LLC, Tustin, California, USA.
John Raymond B ReynaPangea Laboratory LLC, Tustin, California, USA.
Anna E RomanoCalifornia Institute of Technology, Pasadena, California, USA.
Alyssa M CarterCalifornia Institute of Technology, Pasadena, California, USA.
Mi Kyung KimCalifornia Institute of Technology, Pasadena, California, USA.
Matt ThomsonCalifornia Institute of Technology, Pasadena, California, USA.
Colten TognazziniPasadena Public Health Department, Pasadena, California, USA.ORCID 0000-0002-2754-3588
Matthew FeasterPasadena Public Health Department, Pasadena, California, USA.ORCID 0000-0001-9966-2845
Ying-Ying GohPasadena Public Health Department, Pasadena, California, USA.
Yap Ching ChewPangea Laboratory LLC, Tustin, California, USA.
Rustem F IsmagilovCalifornia Institute of Technology, Pasadena, California, USA.ORCID 0000-0002-3680-4399
California Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a recent household transmission study of SARS-CoV-2, we found extreme differences in SARS-CoV-2 viral loads among paired saliva, anterior nares swab (ANS), and oropharyngeal swab specimens collected from the same time point. We hypothesized these differences may hinder low-analytical-sensitivity assays (including antigen rapid diagnostic tests [Ag-RDTs]) by using a single specimen type (e.g., ANS) from reliably detecting infected and infectious individuals. We evaluated daily at-home ANS Ag-RDTs (Quidel QuickVue) in a cross-sectional analysis of 228 individuals and a longitudinal analysis (throughout infection) of 17 individuals enrolled early in the course of infection. Ag-RDT results were compared to reverse transcription-quantitative PCR (RT-qPCR) results and high, presumably infectious viral loads (in each, or any, specimen type). The ANS Ag-RDT correctly detected only 44% of time points from infected individuals on cross-sectional analysis, and this population had an inferred limit of detection of 7.6 × 10

Indexed as

COVID-19SARS-CoV-2Cross-Sectional StudiesHumansLongitudinal StudiesViral LoadCOVID-19diagnosticsevaluationinfectioussensitivity

Identifiers

PMID37314333
PMCPMC10434058
OpenAlexW4380577322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.